rs376868221
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_024589.3(ROGDI):c.822+8C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000102 in 1,225,456 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_024589.3 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ROGDI | NM_024589.3 | c.822+8C>T | splice_region_variant, intron_variant | ENST00000322048.12 | NP_078865.1 | |||
ROGDI | XM_006720947.5 | c.843+8C>T | splice_region_variant, intron_variant | XP_006721010.1 | ||||
ROGDI | XM_047434636.1 | c.573+8C>T | splice_region_variant, intron_variant | XP_047290592.1 | ||||
ROGDI | NR_046480.2 | n.829+8C>T | splice_region_variant, intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ROGDI | ENST00000322048.12 | c.822+8C>T | splice_region_variant, intron_variant | 1 | NM_024589.3 | ENSP00000322832 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00144 AC: 64AN: 44408Hom.: 0 Cov.: 0
GnomAD3 exomes AF: 0.000120 AC: 27AN: 225584Hom.: 0 AF XY: 0.0000974 AC XY: 12AN XY: 123262
GnomAD4 exome AF: 0.0000516 AC: 61AN: 1181048Hom.: 0 Cov.: 37 AF XY: 0.0000465 AC XY: 27AN XY: 580438
GnomAD4 genome AF: 0.00144 AC: 64AN: 44408Hom.: 0 Cov.: 0 AF XY: 0.00141 AC XY: 31AN XY: 22012
ClinVar
Submissions by phenotype
Amelocerebrohypohidrotic syndrome Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago | Aug 18, 2022 | This variant has not been reported in the literature but is present in the Genome Aggregation Database (Highest reported MAF 0.2% (34/16696) (https://gnomad.broadinstitute.org/variant/16-4847707-G-A?dataset=gnomad_r2_1). This variant is present in ClinVar (Variation ID:416250). Evolutionary conservation and computational predictive tools for this variant are limited or unavailable. This variant is an intronic variant with no predicted change in the amino acid sequence but may have an unknown effect on splicing. Splice prediction tools do not suggest that this variant may affect splicing. However, further studies are needed to understand its impact. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
ROGDI-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 11, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at